H2AX and metastatic malignant neoplasm: Since both studies used volunteers who were likely healthier than age-matched patients in the general population, a cohort which included patients with dementia, metastatic cancer, heart disease, and diabetes may have revealed a slope of the γ-H2AX levels after age 50 with an upward trajectory.